Advisory Services Network’s Vir Biotechnology VIR Stock Holding History

Advisory Services Network’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-139	Closed	-$1.25K	–	4539
2026 Q1	$1.25K	Buy	+139	New	+$1.11K	﹤0.01%	4269
2025 Q4	–	Sell	-139	Closed	-$794	–	4161
2025 Q3	$794	Buy	+139	New	+$711	﹤0.01%	3975
2024 Q1	–	Sell	-100	Closed	-$1.01K	–	3592
2023 Q4	$1.01K	Buy	+100	New	+$914	﹤0.01%	3532
2023 Q2	–	Sell	-50	Closed	-$1.16K	–	3588
2023 Q1	$1.16K	Buy	+50	New	+$1.28K	﹤0.01%	3585
2020 Q4	–	Sell	-343	Closed	-$12K	–	3727
2020 Q3	$12K	Buy	+343	New	+$14.8K	﹤0.01%	2358

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Advisory Services Network's VIR Position: Q2 2026 in Review

Advisory Services Network sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 139 shares — an estimated $1.25K sold.

Advisory Services Network first reported a position in VIR in Q3 2020 and held it in 5 quarters. The position peaked at $12K in Q3 2020. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Advisory Services Network reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 139 Vir Biotechnology shares in Q2 2026, an estimated $1.25K.
Advisory Services Network first reported a position in Vir Biotechnology in Q3 2020 and held it in 5 quarters.
Advisory Services Network's Vir Biotechnology position peaked at $12K in Q3 2020.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.